The impact of discontinuing methylphenidate on weight and eating behavior
Copyright policy )The impact of discontinuing methylphenidate on weight and eating behavior
ABSTRACTChronic administration of the amphetamine‐derivative methylphenidate (MPH) may induce appetite reduction and weight loss. By contrast, the effects that stopping chronic MPH may exert on eating behavior and body weight are poorly known.We report the case of a male patient with childhood attention deficit/hyperactivity disorder (ADHD), who discontinued MPH treatment at the age of 11 years and was lost to follow‐up until the age of 16. The patient's body mass index increased by five points within 1 year of MPH cessation while the symptoms of ADHD were re‐emerging. The patient secondarily developed DSM‐5 criteria for eating disorders.Discontinuing chronic MPH can significantly affect weight and eating behavior. Such risks should warrant further studies, as they could be particularly increased in patients with ADHD, who share common vulnerability factors with both obesity and eating disorders. © 2014 Wiley Periodicals, Inc. (Int J Eat Disord 2015; 48:345–348)
Male, Adolescent, methylphenidate, eating disorders, amphetamines, Weight Gain, Body Mass Index, Recurrence, Humans, Central Nervous System Stimulants/therapeutic use*, attention deficit disorder with hyperactivity, weight gain, Feeding Behavior/drug effects*, [SCCO] Cognitive science, Feeding Behavior, Methylphenidate/therapeutic use*, drug toxicity, [SDV] Life Sciences [q-bio], Weight Gain/drug effects*, Attention Deficit Disorder with Hyperactivity, pharmacovigilance, Methylphenidate, Attention Deficit Disorder with Hyperactivity/drug therapy*, Central Nervous System Stimulants
Male, Adolescent, methylphenidate, eating disorders, amphetamines, Weight Gain, Body Mass Index, Recurrence, Humans, Central Nervous System Stimulants/therapeutic use*, attention deficit disorder with hyperactivity, weight gain, Feeding Behavior/drug effects*, [SCCO] Cognitive science, Feeding Behavior, Methylphenidate/therapeutic use*, drug toxicity, [SDV] Life Sciences [q-bio], Weight Gain/drug effects*, Attention Deficit Disorder with Hyperactivity, pharmacovigilance, Methylphenidate, Attention Deficit Disorder with Hyperactivity/drug therapy*, Central Nervous System Stimulants
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).10 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!